1. Relation of upper gastrointestinal bleeding to non-steroidal anti-inflammatory drugs and aspirin: a case-control study
- Author
-
Holvoet, J., Terriere, L., Van Hee, W., Verbist, L., Fierens, E., and Hautekeete, M.L.
- Subjects
Aspirin -- Adverse and side effects ,Gastrointestinal bleeding -- Causes of ,Pain -- Care and treatment ,Nonsteroidal anti-inflammatory drugs -- Adverse and side effects ,Health - Abstract
Several anti-inflammatory, including nonsteroidal anti-inflammatory drugs (NSAIDs), such as aspirin and other drugs, have been implicated as a cause of upper gastrointestinal bleeding. Although there is extensive anecdotal evidence to support this link, only a very few studies involving a very small number of subjects have been performed with adequate control conditions to draw firm conclusions. To further investigate the relationship between anti-inflammatory drugs (aspirin as well as others) and gastrointestinal (GI) bleeding, a study was carried out with 161 patients (102 men and 59 women) who were being treated for either hematemesis (vomiting blood) or melena (blood in stool), and an age-matched control group of patients who were being treated for non-gastrointestinal maladies. There was significantly more use of both non-aspirin NSAIDs and aspirin in the gastrointestinal treatment group. There were no differences between the groups in the extent to which they used other drugs, including acetaminophen, corticosteroids, tobacco, and alcohol. When patient characteristics were calculated for users and non-users of the various drugs, NSAID users were found to be older, more likely to be female, and to have a higher mortality rate than non-users. Among those patients who were found to be suffering from bleeding peptic ulcer disease, NSAID users were equally likely to have reported previous symptoms of ulcer compared with non-users, and did not have a higher frequency of multiple gastric or duodenal ulcers. The increased risk of developing gastrointestinal bleeding attributable to non-aspirin NSAID use was higher than that attributable to the use of aspirin. (Consumer Summary produced by Reliance Medical Information, Inc.)
- Published
- 1991